跳至主要内容
临床试验/EUCTR2009-018054-33-SI
EUCTR2009-018054-33-SI进行中(未招募)不适用

Efficacy of vitamin E and omega-3 unsaturated fatty acid in prevention of damage induced by oxidative stress in patients with schizophrenia

Faculty of Pharmacy, University of Ljubljana0 个研究点开始时间: 2010年4月9日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with schizophrenia, according to DSM IV classification
  • Patients treated with depo haloperidol
  • Male and female voluntaries over 18 years of age
  • Healthy, other than primary disease, according to the medical history, ECG, laboratory results and physical examination as determined by Principal Investigator/Sub-Investigator.
  • Able to comprehend and be informed of the nature of the study. Capable of giving written informed consent prior to receiving any study medication.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Disturbed blood coagulation
  • Treatment with anticoagulants or vitamin K
  • Diabetes mellitus
  • Rheumatoid or psoriatic arthritis

研究者

发起方
Faculty of Pharmacy, University of Ljubljana

相似试验

Efficacy of vitamin E and omega-3 unsaturated fatty... | 临床试验